Safety and efficacy comparison of remimazolam and propofol for intravenous anesthesia during gastroenteroscopic surgery of older patients: A meta-analysis

Figure 3 Forest plots of adverse events after administration of remimazolam or propofol. A: Hypotension; Seven cohort studies reported that the hypotension after administration of remimazolam or propofol the overall estimated prevalence was 44%; B: Respiratory depression; In terms of respiratory depression, four reported that the overall estimated prevalence was 46%; C: Injection pain; Five studies provided comprehensive information regarding the injection pain after administration, with a pooled prevalence of 12%; D: Bradycardia; A total of five cohort studies investigated bradycardia after the two sedatives, with a pooled prevalence of 37%; E: Postoperative nausea and vomiting; In terms of postoperative nausea and vomiting reported in four limited studies, it showed that hat there was no significant difference between the injection of the two drugs; F: Dizziness; A total of three studies investigated dizziness, with a pooled prevalence of 77%.